Onconetix Acquisition Target Realbotix Launches Echo Humanoid Robot Line with Tabletop and Full Body Models Designed for Education, Wellness, and Social Engagement

What happened

Realbotix, which Onconetix has agreed to acquire, launched Echo humanoid robots: the Echo Tabletop at $11,950 and the Echo Full Body at $59,950. A first production run of 250 units is planned, with delivery expected in the second half of 2027.

Confirmed

Global impact / market context

Onconetix is buying Realbotix in an all-stock deal, so Echo gives investors a first look at the products the combined company would sell. The robots target education, wellness and social use, but revenue depends on turning planned production into actual deliveries.

Analyst inference

Humanoid robots are an early-stage category with few proven buyers, so a small first batch of 250 units suggests a cautious launch. Pricing at $11,950 and $59,950 places the robots in a costly range for schools and care providers weighing budgets.

Analyst inference

What to watch

1. Onconetix announced on February 12, 2026 a definitive share exchange agreement to acquire 100% of Realbotix LLC in an all-stock transaction, so completion of that deal is a key step. Confirmed
2. Watch whether Realbotix converts its planned 250-unit first production run into delivered orders in the second half of 2027, since only real sales would show whether buyers want the robots. Proposed
3. Track whether schools and wellness providers commit budgets to robots costing $11,950 to $59,950, because slow adoption would limit revenue and leave the combined company reliant on outside funding. Analyst inference

Evidence

• globenewswire.com